NPHC — Nutra Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.71m
- $9.02m
- $0.44m
Annual cashflow statement for Nutra Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.88 | -6.59 | -0.769 | -13.1 | 8.18 |
| Depreciation | |||||
| Non-Cash Items | 2.38 | 5.41 | -0.438 | 11.2 | -10.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.501 | 0.43 | 0.326 | 0.121 | 1.19 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -1 | -0.744 | -0.878 | -1.74 | -0.762 |
| Capital Expenditures | 0 | — | -0.006 | -0.039 | -0.058 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.255 | 0.085 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | -0.006 | -0.294 | 0.027 |
| Financing Cash Flow Items | -0.057 | -0.129 | 0.232 | -0.077 | -0.164 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1 | 0.744 | 0.884 | 2.13 | 0.644 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0 | 0.091 | -0.091 |